Drug decriminalization stumbled in Oregon. Other states are taking note.

Photo by Andrew Lichtenstein/Corbis via Getty Images

 

Connecting state and local government leaders

The rocky start could slow the movement to treat addiction as a public health matter.

This story is republished from Stateline. Read the original article.

PORTLAND, Ore. — Just before Portland’s city council approved a ban on public drug use last week, Mayor Ted Wheeler described what he’d observed on his way to work that afternoon: “The last time I saw somebody consuming what I believe to be fentanyl publicly on our streets was less than five minutes ago, three blocks from City Hall,” the Democrat said.

The Portland ban, approved unanimously but subject to legislative approval, was the latest repudiation of the state’s recent, groundbreaking approach to drug use.

Oregon voters in 2020 passed Measure 110, a first-in-the-nation law decriminalizing the possession of small amounts of controlled substances such as heroin, methamphetamines, cocaine and fentanyl.

Three years later, public drug use has wearied even the most tolerant of Oregonians. In recent months, Portland has reeled from a record number of opioid overdoses, bad press and a drop in convention and hotel bookings linked to the perception that the city is disorderly and unsafe.

Now, the Oregon law faces significant overhaul or repeal, a prospect likely to slow movements in other states to treat addiction as a public health matter, not a criminal one.

“If we don’t figure out how to get this right, efforts to try this approach in other states probably don’t launch,” said Oregon state Rep. Rob Nosse, a Democrat from Portland who worked on implementation of Measure 110 and who continues to support it.

What went wrong? A state audit found that the law’s rollout was beset by bureaucratic fumbles and a short implementation timeline; a study also has shown the measure’s civil ticketing approach had tepid law enforcement support. More critically, it coincided with a national fentanyl crisis that overwhelmed the country — not just Oregon — with a cheap, addictive and deadly drug.

The measure also took effect during a long-standing homelessness crisis in Oregon and other West Coast states that made public drug use more visible — and discomfiting — in neighborhoods where people live on the streets. It’s particularly problematic in Portland, Oregon’s biggest city, where high rates of commercial property vacancies have hollowed out some downtown sectors.

“People think that Measure 110 has been harmful to Oregon,” said pollster John Horvick of DHM Research, who conducted surveys this spring that found 6 in 10 voters think it has made drug addiction, homelessness and crime worse in Oregon. “That’s really clear. There’s no doubt that that’s where the majority of people are.”

An even more recent poll in Oregon found that 64% of voters want to repeal portions of the measure, including possibly bringing back criminal penalties for possession, and 56% support repealing it entirely. The poll, conducted by Emerson College Polling, was commissioned by the Foundation for Drug Policy Solutions, an Alexandria, Virginia-based organization that opposes decriminalization nationally.

Several rural Oregon counties, but also suburban Clackamas County adjacent to Portland, are considering non-binding advisory ballot measures during the May 2024 election to ask voters whether they think Measure 110 should be repealed.

A group of prominent civic leaders, led by the state’s former head of the Department of Corrections, Max Williams, is pressuring state lawmakers to re-criminalize possession of small amounts of controlled substances, even as they maintain funding for detox and recovery services. It’s an approach Williams and others have dubbed “amend, not end,” but it comes with an implicit threat: If the legislature fails to make timely changes to Measure 110, they’ll ask voters to repeal it in 2024.

Republican state Rep. Jeff Helfrich, a former Portland police officer, argues that without the threat of criminal conviction or prison, there’s no incentive for people with substance use disorders to stop using.

“I am all about let’s get people help, let’s get ’em what they need,” said Helfrich, who represents Hood River, a community about an hour to the east of Portland. “But you have to deter the behavior at some point. And how do you deter that behavior? That’s the million-dollar question.”

Many specialists who work in recovery, though, say reverting to a punitive system to treat addiction won’t get people sober or keep users from overdosing. That’s what they’ve learned in a decade of experience providing service to thousands of opioid users, said Joe Bazeghi, director of engagement at Recovery Works NW, which recently unveiled the first new detox center in the state to open with Measure 110 money.

What we know across the board is that when treatment is voluntarily engaged with, outcomes are better.

– Joe Bazeghi, director of engagement at Recovery Works NW

The 16-bed facility in Portland is expected to serve at least 1,200 people a year, in particular those addicted to fentanyl. People can spend about five days under medically supervised detox before being offered a transition to alcohol and drug treatment and supported housing, Bazeghi said.

“What we know across the board is that when treatment is voluntarily engaged with, outcomes are better,” Bazeghi said. “And we can say that from experience, and we can say that across all our disciplines. That will be the docs, that will be the therapists, that will be the counselors, the peers, the case managers. Everybody backs that up.”

Other States Reconsider

Just to the north in Washington, lawmakers this year raised the state’s penalty for drug possession to a gross misdemeanor. It’s a harsher classification than a misdemeanor, but not a felony. They also criminalized public drug use.

Both actions were in response to a 2021 Washington Supreme Court decision that found the state’s felony drug possession law unconstitutional; a temporary law passed after the ruling lowered felony offenses to misdemeanors. People found in violation while the law was a misdemeanor had to be referred twice to treatment before they could be charged with possession of a controlled substance.

The reaction to Washington’s brief experiment with lesser penalties for possession of a controlled substance proved too politically fraught, said Alison Holcomb, the director of political strategies for ACLU Washington, which supports decriminalization. Donors who had supported a statewide ballot measure similar to Oregon’s were spooked by the backlash, Holcomb said.

“The first impact that we saw was the funders, but then we also saw in the primary and general election in 2022 these narratives being leveraged by candidates,” she said. “Candidates that were looking for easy wins on 1980s, tough-on-crime, War on Drugs rhetoric, were explaining or were arguing that it would be a disaster for Washington to move in the direction of decriminalization.”

Maine lawmakers and policy experts have been watching Oregon carefully. There, the legislature considered but failed in 2021 to pass a bill similar to Oregon’s measure that would turn minor drug possession into civil fines. Winifred Tate, director of the Maine Drug Policy Lab at Colby College, said she’s hopeful discussions will continue. Maine is a small place, Tate said, with people who are committed to addressing its addiction and overdose crises.

“People know each other and have deep relationships,” she said. “That creates opportunities for political change that might be harder on a bigger scale.”

Yet many in Maine are split on whether to move forward with a health care or law enforcement approach to future drug policy. Those fissures have emerged in discussions about how to spend a $235 million settlement with the drug companies that contributed to the opioid crisis.

The quandaries are similar in California, Colorado, Massachusetts and other states considering decriminalization or other approaches aimed at reducing overdoses, including supervised injection sites. Colorado lawmakers considered but ultimately didn’t advance a bill allowing supervised drug use in some cities. And in California last year, Democratic Gov. Gavin Newsom vetoed a pilot program to reduce overdoses that would have allowed supervised injection sites.

Oregon’s Path

Oregon laid out its shortcomings in a state audit released earlier this year that described the launch of Measure 110 as “beset by delays and public friction” that could have been addressed with more proactive management by the Oregon Health Authority. Oregon health officials have acknowledged they were slow to roll out the initial $300 million for Behavioral Health Resource Networks, the treatment and recovery services established in each Oregon county to help fill gaps in addiction services.

The audit also pointed out that the measure had “unrealistic timelines” for implementation. The law decriminalizing possession took effect just three months after the election, before detox and recovery networks were fully built out. It was “a very ambitious timeline,” acknowledged Kellen Russoniello, a senior policy counsel at the Drug Policy Alliance, the New York-based advocacy group behind the ballot measure.

Police in much of the state also were slow to issue civil tickets, which fine drug users up to $100 unless they call an addiction services hotline to have the penalty waived. A study conducted by researchers at Portland State University found that police are skeptical of Measure 110′s ability to motivate people to voluntarily seek treatment. As a result, they’re less willing to hand out citations, said Christopher Campbell, a co-author of the study, and an associate professor in the Department of Criminology and Criminal Justice at the school.

“We spoke to one officer from an urban sheriff’s office and they said that they believe Measure 110 took away the system’s ability to help people recognize rock bottom and kickstart a new life void of drug use,” Campbell said. “So this, along with many other reasons, leaves officers feeling like giving out that citation really isn’t worth their time.”

In 2020 when Oregon voters approved the measure, the state had the second-highest rate of substance use disorder in the nation and was ranked last in providing access to addiction treatment. Fatal overdoses were on the rise.

The status quo wasn’t working and voters knew it, said Tera Hurst, executive director of Health Justice Recovery Alliance, a coalition of organizations working to defend the new law.

“It wasn’t an accident that they overwhelmingly said: ‘No, we believe that addiction is a health care issue. We don’t want to send people to jail and we don’t want to waste our money on that, and it doesn’t work,’” Hurst said.

Hurst notes that since Measure 110 passed, thousands of people are getting help with substance use disorders. In the Portland area alone, 41 organizations received $59 million to ramp up treatment, recovery and peer support programs. Other more rural parts of the state are seeing similar levels of resources, she said, many for the first time.

“There’s more outreach, there’s more drop-in centers, there’s more housing,” Hurst said. “If you stay in the bubble of everything’s awful, you miss all the good that’s happening around.”

So far, Oregon lawmakers have resisted calls to repeal the measure, although they did pass a bipartisan law this year making it a misdemeanor to possess 1 gram or more of fentanyl or five or more pills. Other states slammed by the fentanyl crisis toughened laws around the drug, too, according to the National Conference of State Legislatures. At least 103 laws were enacted, including those that harden penalties for possession and distribution.

I’m not going to say this has been a pretty rollout, but I don’t know that I’ve ever really heard of any new, transformational law going into effect without a lot of bumps.

– Tera Hurst, executive director of Health Justice Recovery Alliance

This fall, some Oregon lawmakers will travel overseas to Portugal to see how officials there have managed more than two decades of decriminalization. “This will give us a greater understanding of what trials and tribulations Portugal went through over their journey,” said Democratic state Sen. Floyd Prozanski, a municipal prosecutor who chairs the Senate Judiciary Committee.

Advocates continue to plead for more time, saying that such a massive societal shift in how Americans consider addiction requires more time to take hold. And no state is immune from discussions on how to address an epidemic of opioid-related deaths. Accidental overdoses are now the No. 1 cause of death for young people in 37 states.

“I’m not going to say this has been a pretty rollout,” Hurst said, “but I don’t know that I’ve ever really heard of any new, transformational law going into effect without a lot of bumps.”

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.